Putting Science to Work

Archives / 2018 / August

  • Syngene International Q1 net profit up 6% at Rs 66 crore

    PharmaBiz- 26/07/2018. The quarter saw good performance within biologics manufacturing, discovery services and chemical development services as well as a benefit from improved FX rates.


Discovery Chemistry Discovery Biology Safety Assessment Large Molecule Development Chemical Development Formulation Development Stability Studies Polymer Research Integrated Discovery & Development Clinical Development Services Bioinfomatics Antibody Drug Conjugates Oligonucleotide Synthesis Contact Us

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget